Followers | 130 |
Posts | 18112 |
Boards Moderated | 0 |
Alias Born | 01/16/2007 |
Wednesday, February 10, 2016 1:36:01 PM
Tuesday, February 9, 2016
New Release Updates - HHSE / MEDALLION
Dear HHSE Friends & Followers - As the Company continues to build and grow, one of the areas that offers the best means of rapidly expanding revenues is to license films into the international market for original productions. Accordingly, beginning in earnest at the Cannes Film Festival and Marche Du Filme (this May, 2016), HHSE and Medallion Releasing will be promoting FIVE significant (major theatrical caliber) features, along with FOUR (4) lower-budgeted features (designed primarily for direct-to-video or VOD, or with a limited theatrical launch).
CANNES 2016 PREVIEW:
MAJOR PRODUCTIONS - MID-LEVEL-TO-WIDE USA THEATRICAL RELEASES
"MELTDOWN" - $10-mm Production, major star in lead; Terrorism-Action Theme.
"LEGEND OF BELLE STARR" - $3.5-mm Production, major star in lead; Historic / Action / Western.
"MOTHER GOOSE: JOURNEY TO UTOPIA" - $12-mm Production, three major stars; Family / Fantasy / Adventure.
"DELIRIUM" - $1.5-mm Production, solid cast - Sci-Fi / Horror.
"PATHWAY TO FREEDOM" - $1.5-mm Production, solid cast - Historic / Drama
LOWER BUDGETED RELEASES - LIMITED THEATRICAL OR DTV
"TRUE FRESHMAN" - Solid Cast / Football / Action / Pro-Family Drama
"CLOWN TOWN" - Abandoned Theme Park, Sci-Fi/Horror.
"SHUCK AND JIVE" - Urban-themed Drama / based on a true story.
"SHADOW VISION" - Sci-Fi / Thriller
HHSE and Medallion anticipate that these nine titles will be the major locomotives most responsible for driving record revenues for the Company in both 2016 and 2017. More details will be released prior to the Cannes Market.
http://hannoverhousemovies.blogspot.com/2016/02/new-release-updates-hhse-medallion.html
HHSE
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM